BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23928994)

  • 1. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma.
    Zhang Y; Sturgis EM; Dahlstrom KR; Wen J; Liu H; Wei Q; Li G; Liu Z
    Cancer Res; 2013 Oct; 73(19):5996-6003. PubMed ID: 23928994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
    Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
    Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.
    Zhang Y; Sturgis EM; Sun Y; Sun C; Wei Q; Huang Z; Li G
    Eur J Cancer; 2015 Jul; 51(11):1415-23. PubMed ID: 25981582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
    Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
    Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TGF-β1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.
    Tao Y; Sturgis EM; Huang Z; Sun Y; Dahlstrom KR; Wei Q; Li G
    Int J Cancer; 2018 Sep; 143(6):1327-1334. PubMed ID: 29663347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.
    Yuan Y; Sturgis EM; Zhu L; Lu M; Li Y; Wei Q; Li G
    Mol Carcinog; 2017 Mar; 56(3):1100-1106. PubMed ID: 27677255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint effect of human papillomavirus exposure, smoking and alcohol on risk of oral squamous cell carcinoma.
    Yang Z; Sun P; Dahlstrom KR; Gross N; Li G
    BMC Cancer; 2023 May; 23(1):457. PubMed ID: 37202767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
    Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma.
    Chen X; Sturgis EM; Lei D; Dahlstrom K; Wei Q; Li G
    Cancer Res; 2010 Sep; 70(18):7199-208. PubMed ID: 20736372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck.
    Zhou Z; Sturgis EM; Liu Z; Wang LE; Wei Q; Li G
    Mol Carcinog; 2012 Oct; 51 Suppl 1(Suppl 1):E54-64. PubMed ID: 22086558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
    PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA variants increase the risk of HPV-associated squamous cell carcinoma of the oropharynx in never smokers.
    Song X; Sturgis EM; Liu J; Jin L; Wang Z; Zhang C; Wei Q; Li G
    PLoS One; 2013; 8(2):e56622. PubMed ID: 23457596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma.
    Jin L; Sturgis EM; Zhang Y; Huang Z; Song X; Li C; Wei Q; Li G
    Mol Cancer; 2013 Jul; 12():80. PubMed ID: 23870134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
    Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
    Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined p53-related genetic variants together with HPV infection increase oral cancer risk.
    Wang Z; Sturgis EM; Zhang Y; Huang Z; Zhou Q; Wei Q; Li G
    Int J Cancer; 2012 Aug; 131(3):E251-8. PubMed ID: 22052649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.